Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

New [18F]fluorinated PSMA agents show potential for PET imaging of prostate cancer

Oct. 25, 2016

Multiplatform imaging of systemic amyloidosis with the new peptide p5+14

Oct. 24, 2016

PSMA ligand [99mTc]MIP-1427 improves diagnostics in osseous metastasized prostate cancer

Oct. 20, 2016

HiberGene announces launch of HG Group B Streptococcus direct swab test

Oct. 19, 2016

In vivo results of the novel PDE4D-sparing PDE4 PET radioligand [18F]PF-06445974

Oct. 19, 2016

[18F]PSMA-1007: a promising new F-18-labeled PSMA-targeting PET tracer

Oct. 19, 2016

Brain imaging successful with [11C]CB-184 in healthy human subjects

Oct. 18, 2016

Positive opinion handed down in E.U. for SomaKit TOC

Oct. 18, 2016

89Zr-Girentuximab imaging evaluated in first-in-human renal cell carcinoma study

Oct. 18, 2016

Myocardial PET imaging with CardioPET shows promise in phase II study

Oct. 17, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...